News from avacen medical A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Sep 20, 2018, 07:48 ET Autism Spectrum Disorder (ASD) "Fever Effect" Pilot Study Enrollment Begins

AVACEN Medical, Inc. (AVACEN) announced the beginning of subject enrollment of subjects in its sponsored 12-family blinded, double placebo-controlled ...


Jun 13, 2018, 08:45 ET Autism Spectrum Disorder (ASD) "Fever Effect" Pilot Study Enrollment Announced

AVACEN Medical, Inc. (AVACEN), announced that it will be sponsoring a 12-family blinded, double placebo-controlled pilot study of ASD children ages...


Jan 22, 2018, 07:55 ET AVACEN Medical Device for Autistic Spectrum Disorder Behavior Management Launched in Hong Kong

AVACEN Medical, Inc. (AVACEN) announced that it is launching sales of its AVACEN 100, an FDA-cleared and CE marked, class II dry-heat therapy medical ...


Jan 17, 2018, 08:00 ET Medical Device for Relief of Autistic Behavior to be Launched in India

AVACEN Medical, Inc. (AVACEN) announced that it is launching sales of its AVACEN 100, an FDA-cleared and CE marked class II dry-heat therapy medical...


Dec 29, 2017, 14:26 ET AVACEN Medical Announces Autism Clinical Trial

AVACEN Medical (AVACEN) announced it will be using Crowdfunder.com to fund a double-blind, randomized, placebo-controlled clinical study in the first ...


Oct 12, 2017, 08:05 ET AVACEN Medical Recipient of Frost & Sullivan's 2017 New Product Innovation Award for Its Fibromyalgia Pain Management Device

AVACEN Medical, Inc. (AVACEN) announced that Frost & Sullivan has recognized the company with their 2017 New Product Innovation Award for Its...


Sep 26, 2017, 08:30 ET Health Canada Grants the First Class II Medical Device License for Systemically Treating the Widespread Pain Associated With Fibromyalgia

AVACEN Medical, Inc. (AVACEN) announced that its AVACEN 100 Class ll medical device previously licensed for treating joint pain associated with...


Sep 22, 2017, 08:40 ET New Medical Device Successfully Treating Fibromyalgia Pain in the EU

AVACEN Medical (AVACEN) announced that its CE-Marked AVACEN 100 Class ll medical device is now successfully helping those with the widespread pain...


Aug 24, 2017, 08:29 ET AVACEN Medical Introduces a New Concept for Treating Fibromyalgia Widespread Pain to India

AVACEN Medical (AVACEN) announced partnering with Morulaa HealthTech of Chennai, India to introduce its FDA-cleared and CE Marked AVACEN 100, Class...


Aug 08, 2017, 09:23 ET AVACEN Medical Introduces New Concept for Treating Arthritis Pain to India

AVACEN Medical (AVACEN) announced partnering with Morulaa HealthTech of Chennai, India to introduce its FDA-cleared AVACEN 100, Class II medical...


Aug 04, 2017, 08:17 ET AVACEN Medical Receives CE (Conformité Européenne) Mark for Increasing Microcirculation and Treating Widespread Fibromyalgia Pain

AVACEN Medical (AVACEN) announced its AVACEN 100, Class II, OTC medical device has received the CE (Conformité Européenne) Mark approval to treat...


Jul 21, 2017, 08:04 ET Introduction of New Concept in Wound-Healing Expected to Dramatically Reduce Amputations in India

AVACEN Medical (AVACEN) announced partnering with Morulaa HealthTech of Chennai, India to introduce its AVACEN 100, Class II medical device, in India....


Jun 30, 2017, 11:18 ET New Research Published Describing an Innovative Concept for Treating Widespread Fibromyalgia Pain

AVACEN Medical (AVACEN) announced the publication of new research in the peer-reviewed Fibromyalgia Open Access Journal. The research describes the...


Jun 15, 2017, 08:30 ET AVACEN Medical and CellMark Medical Form Strategic Partnership to Globally Market the AVACEN-100 Medical Device

AVACEN Medical (AVACEN) announced it has partnered with CellMark Medical (CellMark) for the international sale and marketing of its AVACEN-100,...


May 23, 2017, 07:50 ET New Concept for Treating Pain Approved by Health Canada

AVACEN Medical (AVACEN) announced its CE marked AVACEN 100, Class-II, medical device has received Health Canada Medical Device License approval. The...


Dec 23, 2016, 07:44 ET New Concept for Treating Widespread Pain Approved for European Union Fibromyalgia Market

AVACEN Medical (AVACEN) announced its AVACEN 100, Class-IIa, OTC medical device has received the CE (Conformité Européenne) Mark approval to treat...


Oct 13, 2016, 08:30 ET AVACEN Medical Announces Support for New ClinicalTrials.gov Initiative

Today AVACEN Medical (AVACEN), a medical device company, whose fibromyalgia clinical trial results can be found on ClinicalTrials.gov, announced it...


Jul 05, 2016, 08:55 ET AVACEN Medical Selected for 2016 MetroConnect Grant

San Diego Mayor Kevin Faulconer and World Trade Center San Diego have announced that AVACEN Medical has been selected to take part in the...


Dec 11, 2015, 09:08 ET Encouraging Fibromyalgia Study Results Now Available at ClinicalTrials.gov

AVACEN Medical announced today that ClinicalTrials.gov, a service of the U.S. National Institutes of Health, has published the results of the...


Nov 25, 2015, 08:40 ET New Concept for Chronic Pain Treatment Patent Issued

Today AVACEN Medical announced the issue of United States patent No. 9,192,509 entitled: "Methods and Apparatus for Therapeutic Application of...


Sep 08, 2015, 09:39 ET Drug-Free, Rapid Whole-Body Muscle Relaxation Solution to be Introduced at "PAINWeek" in Las Vegas

AVACEN Medical announced today that it will be introducing its FDA cleared noninvasive AVACEN 100 muscle relaxation medical device at PAINWeek on...


Dec 30, 2014, 08:50 ET AVACEN Medical Launches $2 Million CrowdFunder.com Campaign in Response to Positive Fibromyalgia Study Results

AVACEN Medical announced today that it has launched a $2 million campaign on Crowdfunder.com to support further company clinical trials and FDA...


Oct 22, 2014, 08:30 ET AVACEN Medical Announces FDA Clearance of First Medical Device with Internal Game Mode

AVACEN Medical announced today that its AVACEN 100 Class II medical device received 510 (k) OTC clearance by the U.S. Food and Drug Administration....